Robecosam AG continued to hold its position in shares of BioAmber Inc. (NYSE:BIOA) during the third quarter, Holdings Channel reports. The fund owned 400,000 shares of the company’s stock at the end of the third quarter. Robecosam AG owned approximately 1.39% of BioAmber worth $1,604,000 as of its most recent SEC filing.
Separately, Essex Investment Management Co. LLC boosted its position in shares of BioAmber by 21.0% in the third quarter. Essex Investment Management Co. LLC now owns 122,619 shares of the company’s stock worth $520,000 after buying an additional 21,257 shares in the last quarter. 34.82% of the stock is currently owned by institutional investors and hedge funds.
Shares of BioAmber Inc. (NYSE:BIOA) traded down 5.87% during mid-day trading on Wednesday, reaching $3.37. The company had a trading volume of 439,908 shares. The firm has a 50 day moving average of $4.78 and a 200-day moving average of $4.41. BioAmber Inc. has a one year low of $2.86 and a one year high of $6.50. The stock’s market capitalization is $97.18 million.
A number of brokerages have recently commented on BIOA. Zacks Investment Research raised BioAmber from a “hold” rating to a “buy” rating and set a $4.25 price target on the stock in a research report on Tuesday, November 8th. AltaCorp Capital reaffirmed an “outperform” rating on shares of BioAmber in a research report on Wednesday, January 4th.
BioAmber Inc (BioAmber), formerly DNP Green Technology, Inc, is an industrial biotechnology company, which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products.
Want to see what other hedge funds are holding BIOA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BioAmber Inc. (NYSE:BIOA).